Gene Technology 2 Flashcards
(21 cards)
Genome Sequencing
Finding the sequence of bases in a DNA molecule
Genome
Total Genetic make-up of an organism
Virus - genetic info in its DNA strand (or RNA retrovirus)
Prokaryote - comp of single loop of naked DNA and any plasmids present
Eukaryote - complete nucleotide sequence in a haploid set of chromosomes
Genome Sequencing Organsims
•orgs that are used in genetic research - used extensively in study of heredity and gene function
•orgs that can cause disease - bacterium E. coli pathogenic, and parasites Plasmodium - malaria
•orgs that can provide valuable info about evolutionary ancestry of the modern human - chimpanzees and neanderthal
Proteome
Entire set of proteins expressed by a genome
The Human Genome
•more than 3 billion base pairs
•more than half of non-coding DNA consists of variable repeat sequences
•98% DNA does not code for proteins
•2% DNA codes for proteins and includes 21000 genes
•Single nucleotide substitutions occur in coding & non-coding areas - variants called SNPs
•in polypeptide-coding genes , SNPs represent allelic differences and are used as markers of variation
•SNPs vary in only about 0.1% human genome - accounts for thousands diff alleles
•SNP alleles identified which are linked to genetic disease, predisposition to disease and to diff responses to drugs
SNPs
Single Nucleotide Polymorphisms
Applications of Genome Sequencing
- Creating Phylogenetic Trees
- Detecting Genetic Disease
- Detecting Predisposition to Certain Diseases
- Analysing genomes of pathogens
- Creating 3D models of protein structure
- Producing Personalised Medicine
What does Genetic Testing using Microarrays commonly determine
•genotypes in multiple regions of a genome - defected detected for diagnosing disease
•gene expression for a large number of genes simultaneously
Gene Expression
A gene is expressed when its switched on so that mRNA is transcribed to encode the synthesis of a protein
Microarrays
Gene Chips or DNA Chips
Consist of hundreds to tens of thousands of different DNA probes anchored within spots to a solid surface
Each spot contains many molecules of particular probe - diff spots possess probes comp to diff known genes
Principle behind microarray technology
Hybridisation between the DNA probe and any complementary single stranded DNA obtained from tissue tested
Genotyping
DNA from person being tested extracted, genes cut out, made single stranded and labelled w/ fluorescent dye
After adding to microarray, DNA fragment hybridises with probe, colour change occurs
Computer analysis of results will reveal whole range of genes in persons genome incl faulty alleles of particular genes
Testing for Gene Expression
mRNA extracted from tissue and converted, using reverse transcriptase enzyme, into single stranded copy DNA (cDNA) each w/ fluorescent tag
Labelled cDNA molecules added to microarray and will hybridise with any complementary probe
Hybridisation of cDNA and probe indicates that gene was expressed in the tissue
Diagnosing Activity of Oncogenes Using Microarrays
Labelled cDNA prod from mRNA extracted from healthy and cancer tissue
-diff fluorescent dyes used to tag
Mixture of both sources added to microarray so both hybridise probes
Microarray scanned with laser - exciting tags and generating signals - strength dependant on amt of cDNA binding to probes at each spot
Spots with both colours tags mixed show genes that are active in both healthy and cancer tissue
Spots of healthy colour are switched off in cancer tissue
Spots of cancer colour are switched on in cancer tissue - some of which oncogenes which may be deactivating or activating other genes
Pharmacogenetics
Study of genetic differences in drug metabolic pathways - which affect individual responses to drugs
Inactivation of Drugs
CYP2 enzymes responsible for breakdown drugs - activity depends on which allele responsible for production
Some rapid-metabolising some poor metabolisers
Clinical effect greater in poor metabolised because of rate of elimination of drug
Standard dose of drugs rapid vs poor metabolisers
Rapid Metabolisers may get no benefit from drug
Poor metabolisers may suffer effects of an overdose
Activation of Drugs
Codeine mist be first converted by enzyme CYP2D6 to its active form morphine before becoming effective
Gene encoding for enzyme is CYP2D6 - variant alleles
Poor metaboliser gets no pain relief - Rapid incr risk of breathing problems
Personalised Medicine
Choosing treatments for people based on knowledge of individual personal genetic profiles rather than using the same treatment for all
Breast cancer gene
30% HER2 gene
Activity shut down by trastuzumab - expensive and ass with cardiac toxicity
Designer Drugs
Drugs created to match an individuals genetic profile